Dassault Systèmes invests in Click Therapeutics

PARIS: Dassault Systèmes, through its MEDIDATA brand, has deepened its collaboration with Click Therapeutics, investing in cutting-edge solutions to enhance patient engagement and real-world care. The partnership aims to set a gold standard for digital and pharmaceutical clinical trials, paving the way for advancements in Prescription Digital Therapeutics (PDTs) and Software-Enhanced (SE) products.

MEDIDATA’s technology, which supports over 8,000 studies annually, will now extend its reach to support real-world evidence generation and improved patient outcomes. Click Therapeutics will gain access to Dassault Systèmes’ global expertise, pushing the boundaries of medicine with software-driven treatments.

“Digital therapeutics are revolutionizing clinical development,” said Anthony Costello, CEO of MEDIDATA. “This partnership ensures patients benefit from innovative, reliable solutions throughout their healthcare journey.”

David Benshoof Klein, CEO of Click Therapeutics, emphasized the FDA’s growing focus on software in medicine, stating, “Our collaboration with Dassault Systèmes expands treatment possibilities for patients, moving medicine into the digital age.”